# Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Middle Ear Infections

> **NCT04761562** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Medical Centre Ljubljana** · enrollment: 100 (estimated)

## Conditions studied

- Otitis Media Chronic
- Tympanic Membrane Perforation

## Interventions

- **DRUG:** Platelet- and extracellular vesicle-rich plasma
- **PROCEDURE:** Control group

## Key facts

- **NCT ID:** NCT04761562
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-14
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04761562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04761562, "Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Middle Ear Infections". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04761562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*